(Q40852223)

24 September 2017

1 reference

title

Angiotensin-converting enzyme inhibitors in diabetic nephropathy (English)

1 reference

24 September 2017

W R Melchior

1

1 reference

24 September 2017

V Bindlish

series ordinal

2

1 reference

24 September 2017

L A Jaber

series ordinal

3

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 March 1993

1 reference

Annals of Pharmacotherapy

24 September 2017

published in

1 reference

24 September 2017

volume

27

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

344-350

1 reference

Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

The problem of diabetic renal failure in the United States: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Racial differences in the relation between blood pressure and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Diabetic nephropathy: hemodynamic basis and implications for disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Short- and long-term effects of calcium entry blockers on the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Effects of different calcium antagonists on proteinuria associated with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Angiotensin-converting enzyme inhibitors in the prevention of experimental diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Reduction of albuminuria after angiotensin converting enzyme inhibition in various renal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

Initial effect of enalapril on kidney function in patients with moderate to severe chronic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809302700318

10.1177/106002809302700318

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference